Chinese Journal of Clinical Hepatology最新文献

筛选
英文 中文
IDDF2022-ABS-0246 NGFR+ hepatic stellate cell 1 (HSC1) and α-SMA+ HSC2 graft infiltration, but not donor steatotic grading, predicted post-operative graft survival outcome in liver transplantation IDDF2022-ABS-0246 NGFR+肝星状细胞1 (HSC1)和α-SMA+ HSC2移植物浸润,而不是供体脂肪变性分级,预测肝移植术后移植物存活结果
Chinese Journal of Clinical Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.128
Sui-Yan Tam, Yum-Hung Fredrick Cheng, Wai-Ho Oscar Yeung, Kwan Man
{"title":"IDDF2022-ABS-0246 NGFR+ hepatic stellate cell 1 (HSC1) and α-SMA+ HSC2 graft infiltration, but not donor steatotic grading, predicted post-operative graft survival outcome in liver transplantation","authors":"Sui-Yan Tam, Yum-Hung Fredrick Cheng, Wai-Ho Oscar Yeung, Kwan Man","doi":"10.1136/gutjnl-2022-iddf.128","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.128","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86083523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0023 Associations between six dietary habits and risk of hepatocellular carcinoma: a mendelian randomization study 六种饮食习惯与肝细胞癌风险之间的关联:一项孟德尔随机研究
Chinese Journal of Clinical Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.89
Y. Deng, Junjie Huang, M. Wong
{"title":"IDDF2022-ABS-0023 Associations between six dietary habits and risk of hepatocellular carcinoma: a mendelian randomization study","authors":"Y. Deng, Junjie Huang, M. Wong","doi":"10.1136/gutjnl-2022-iddf.89","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.89","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83455191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0171 Frequency and risk factors for complications after ultrasound-guided percutaneous liver radiofrequency ablation in 363 sessions 超声引导下363例经皮肝射频消融术后并发症的发生频率和危险因素
Chinese Journal of Clinical Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.110
Engelbert Simon Perillo, Virgilio Lo, Stephen C. Wong
{"title":"IDDF2022-ABS-0171 Frequency and risk factors for complications after ultrasound-guided percutaneous liver radiofrequency ablation in 363 sessions","authors":"Engelbert Simon Perillo, Virgilio Lo, Stephen C. Wong","doi":"10.1136/gutjnl-2022-iddf.110","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.110","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90383689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0073 HCC surveillance program in a nurse-led clinic: assessing adherence to guidelines and possibility of reducing pressure on services by applying AMAP score IDDF2022-ABS-0073护士主导诊所的HCC监测项目:通过应用AMAP评分评估对指南的依从性和减少服务压力的可能性
Chinese Journal of Clinical Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.96
M. Elnagar, M. Saleem, A. Beard, Samantha Whyld, A. Austin
{"title":"IDDF2022-ABS-0073 HCC surveillance program in a nurse-led clinic: assessing adherence to guidelines and possibility of reducing pressure on services by applying AMAP score","authors":"M. Elnagar, M. Saleem, A. Beard, Samantha Whyld, A. Austin","doi":"10.1136/gutjnl-2022-iddf.96","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.96","url":null,"abstract":"BackgroundNICE recommends offering 6 monthly surveillance with USS for all cirrhotic patients with an exception for patients identified for end-of-life care. But surveillance intervals are often missed when care is delivered through Consultant-led clinics. Having introduced a nurse-led stable cirrhosis clinic in 2016, we assessed whether the recommended interval was being achieved and what impact the ‘aMAP’ score stratifying annual HCC risk as low (<0.2%), medium (1%) and high (4%) might have on service utilisation.MethodsA retrospective review of all patients attending our nurse-led stable cirrhosis clinic. The review included demographic data, aetiology of liver disease, and calculation of aMAP (age, gender, albumin-bilirubin) scores using parameters from initial clinic visits. We assessed adherence to the twice-yearly US scan since our adaptation of NICE guidelines in 2018.ResultsBetween 2016–2018, 117 (49 female) cirrhotic patients were enrolled in the clinic. The majority of the patients had ALD (55) and NASH (24). Other aetiologies: HCV, HFE and PBC. All patients had Child A disease except 7 with Child B7–8. 13/117 patients were excluded from the surveillance because of other co-morbidities and age. Of the remaining, 90(87%) patients had their USS at 6 months interval, 2(2%) missed only one scan (not requested by clinician), 7(7%) failed to attend their appointments, 5(4%) either declined surveillance or were lost to follow up. aMAP score identified 70/104(67%) high risk, 29(28%) medium risk and only 5(5%) low risk for HCC. HCC was diagnosed in 4/104 patients after 3 years of follow-up (2 medium risks;2 high risks). Death was reported in 10 (1HCC;4 liver failure;3 other cancers;1 post-operative complication;1 sepsis). Despite interruptions caused by the COVID-19 pandemic, no HCC was diagnosed in 1st US scan after restarting the services.ConclusionsHCC surveillance organised through a dedicated nurse-led stable cirrhosis clinic can achieve excellent adherence to planned USS intervals. Only a small number were identified as low risk within our cohort using the aMAP score offering limited opportunity to reduce the volume of USS for this indication in Derby.","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75152880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0112 Clinical features in primary biliary cholangitis: a retrospective analysis of 52 cases 52例原发性胆道胆管炎临床特点回顾性分析
Chinese Journal of Clinical Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.97
Jing-Ping Zhou, Mei-ya Chen, Fei Zhou, Er'mei Chen, Ligang Chen, Jianlin Ren, Rui Li
{"title":"IDDF2022-ABS-0112 Clinical features in primary biliary cholangitis: a retrospective analysis of 52 cases","authors":"Jing-Ping Zhou, Mei-ya Chen, Fei Zhou, Er'mei Chen, Ligang Chen, Jianlin Ren, Rui Li","doi":"10.1136/gutjnl-2022-iddf.97","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.97","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85627386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0167 Performance of abbreviated magnetic resonance imaging versus ultrasonography as an imaging tool for hepatocellular carcinoma surveillance 缩短磁共振成像与超声作为肝细胞癌监测成像工具的性能比较
Chinese Journal of Clinical Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.108
Huttakan Navadurong, K. Laohasurayotin, Kan Yorwittaya, Thodsawit Tiyarattanachai, Natthaporn Tanpowpong, N. Pisuchpen, R. Chaiteerakij, S. Treeprasertsuk, R. Rerknimitr
{"title":"IDDF2022-ABS-0167 Performance of abbreviated magnetic resonance imaging versus ultrasonography as an imaging tool for hepatocellular carcinoma surveillance","authors":"Huttakan Navadurong, K. Laohasurayotin, Kan Yorwittaya, Thodsawit Tiyarattanachai, Natthaporn Tanpowpong, N. Pisuchpen, R. Chaiteerakij, S. Treeprasertsuk, R. Rerknimitr","doi":"10.1136/gutjnl-2022-iddf.108","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.108","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81868412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0145 Comparative effectiveness of different techniques of endoscopic hemostasis in active variceal bleeding 内镜下不同止血技术治疗活动性静脉曲张出血的疗效比较
Chinese Journal of Clinical Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.105
I. Savostyanov, A. Korotkevich
{"title":"IDDF2022-ABS-0145 Comparative effectiveness of different techniques of endoscopic hemostasis in active variceal bleeding","authors":"I. Savostyanov, A. Korotkevich","doi":"10.1136/gutjnl-2022-iddf.105","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.105","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87886667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0193 Outcomes of preoperative transarterial chemoembolization (TACE) compared to upfront liver resection for large (≥5cm) hepatocellular carcinoma (HCC): a systematic review and meta-analysis 术前经动脉化疗栓塞(TACE)与术前肝切除术治疗大型(≥5cm)肝细胞癌(HCC)的疗效比较:一项系统回顾和荟萃分析
Chinese Journal of Clinical Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.119
Feng-Yi Cheo, K. Chan, W. Tay, V. Shelat
{"title":"IDDF2022-ABS-0193 Outcomes of preoperative transarterial chemoembolization (TACE) compared to upfront liver resection for large (≥5cm) hepatocellular carcinoma (HCC): a systematic review and meta-analysis","authors":"Feng-Yi Cheo, K. Chan, W. Tay, V. Shelat","doi":"10.1136/gutjnl-2022-iddf.119","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.119","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75565966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0174 The optimal cut-off values of serum ceruloplasmin and urinary copper in the diagnosis of wilson disease in CHB patients 血清铜蓝蛋白和尿铜在CHB wilson病诊断中的最佳临界值
Chinese Journal of Clinical Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.111
Jiahui Pang, Shuru Chen, Meng Yu, Heping Wang, Y. Zeng, Y. Chong, Jiao Gong, W. Gan, Xinhua Li
{"title":"IDDF2022-ABS-0174 The optimal cut-off values of serum ceruloplasmin and urinary copper in the diagnosis of wilson disease in CHB patients","authors":"Jiahui Pang, Shuru Chen, Meng Yu, Heping Wang, Y. Zeng, Y. Chong, Jiao Gong, W. Gan, Xinhua Li","doi":"10.1136/gutjnl-2022-iddf.111","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.111","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74900411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0170 Hypoxia and R-factor: predictors of abnormal lft in covid-19 低氧和r因子:covid-19患者异常左移的预测因素
Chinese Journal of Clinical Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.109
W. Chew, Jonathan Kuang, Huiyu Lin, L. Ang, W. Yang, D. Lye, B. Young
{"title":"IDDF2022-ABS-0170 Hypoxia and R-factor: predictors of abnormal lft in covid-19","authors":"W. Chew, Jonathan Kuang, Huiyu Lin, L. Ang, W. Yang, D. Lye, B. Young","doi":"10.1136/gutjnl-2022-iddf.109","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.109","url":null,"abstract":"IDDF2022-ABS-0170 Table 1Demographics, comorbidities, laboratory investigations and clinical outcomes of COVID-19 patients stratified by ALT All (n=163) Status of ALT P-value¶ Characteristics Abnormal (n=50) Normal (n=113) Age in years, median (IQR) 56 (43–65) 60 (50–67) 55 (37–64) 0.022 Gender, n (%) 0.124 Male 96 (58.9) 34 (68.0) 62 (54.9) Female 67 (41.1) 16 (32.0) 51 (45.1) Ethnic group, n (%) 0.520 Chinese 98 (60.1) 34 (68.0) 64 (56.6) Malay 18 (11.0) 4 (8.0) 14 (12.4) Indian 20 (12.3) 6 (12.0) 14 (12.4) Others 27 (16.6) 6 (12.0) 21 (18.6) Comorbidities, n (%) Diabetes 32 (19.6) 13 (26.0) 19 (16.8) 0.201 Hyperlipidemia 57 (35.0) 24 (48.0) 33 (29.2) 0.032 Hypertension 61 (37.4) 26 (52.0) 35 (31.0) 0.014 Ischemic heart disease 15 (9.2) 7 (14.0) 8 (7.1) 0.238 Chronic liver disease 4 (2.5) 1 (2.0) 3 (2.7) 1.000 Charlson Comorbidity Index, median (IQR) 0 (0–1) 0 (0–1) 0 (0–1) 0.400 BMI, kg/m2, median (IQR), n=46 24.3 (23.2–27.9) 22.9 (22.1–24.2) 24.6 (23.6–28.7) 0.011 GI symptoms, n (%) Diarrhoea 29 (17.8) 12 (24.0) 17 (15.0) 0.186 Abdominal pain 4 (2.5) 0 (0.0) 4 (3.5) 0.313 Nausea/vomiting 10 (6.1) 0 (0.0) 10 (8.8) 0.032 Abnormal chest radiography on admission 55 (33.7) 22 (44.0) 33 (29.2) 0.074 Laboratory investigations on admission, median (IQR) ALT, U/L 23 (18–31) 29 (22–33) 21 (17–26) <0.0005 ALT/LDH ratio, n=162 0.05 (0.04–0.07) 0.06 (0.04–0.07) 0.05 (0.03–0.06) 0.039 ALP 72 (60–89) 72 (61–90) 72 (60–89) 0.700 R factor 0.94 (0.70–1.26) 1.15 (0.86–1.49) 0.87 (0.63–1.19) <0.0005 WBC, x109/L 4.70 (3.80–5.70) 4.75 (3.80–5.83) 4.70 (3.85–5.70) 0.844 Lymphocyte, x109/L 1.11 (0.84–1.49) 0.99 (0.74–1.23) 1.20 (0.87–1.65) 0.002 PLT, x 109/L 188 (150–225) 177 (142–223) 193 (155–226) 0.306 CRP, mg/L, n=162 10.75 (3.15–39.40) 30.10 (11.28–50.65) 6.85 (1.95–23.88) <0.0005 LDH, U/L, n=162 420 (350–547) 482 (378–572) 408 (342–525) 0.033 Creatinine, μmol/L 72 (61–87) 76 (65–88) 71 (59–87) 0.288 Albumin, g/L, n=156 39 (37–42) 39 (37–41) 40 (37–43) 0.044 BIL, μmol/L, n=152 11 (9–14) 11 (9–14) 12 (9–15) 0.555 Medication used, n (%) NSAIDs 22 (13.5) 4 (8.0) 18 (15.9) 0.218 β-lactam 47 (28.8) 22 (44.0) 25 (22.1) 0.008 Hydroxychloroquine 7 (4.3) 1 (2.0) 6 (5.3) 0.677 Lopinavir/Ritonavir (Kaletra) 25 (15.3) 16 (32.0) 9 (8.0) <0.0005 Remdesivir 12 (7.4) 5 (10.0) 7 (6.2) 0.516 Interferon 9 (5.5) 6(12.0) 3 (2.7) 0.025 Days of symptoms before admission, median (IQR) 4 (3–7) 4 (2–7) 5 (3–7) 0.396 Length of stay in days, median (range) 13(8–17) 16(13–24) 11 (7–16) <0.0005 Clinical severity HDU/ICU, n (%) 29 (17.8) 16 (32.0) 13 (11.5) 0.003 Required supplementary oxygen, n (%) 50 (30.7) 29 (58.0) 21 (18.6) <0.0005 Days on supplementary oxygen, median (IQR), n=50 11 (6–18) 12 (6–21) 8 (5–15) 0.15 Intubated, n (%) 13 (8.0) 10 (20.0) 3 (2.7) <0.0005 Death, n (%) 5 (3.1) 3 (6.0) 2 (1.8) 0.169 Sample size, n=163, except where indicated.¶ P values are from Fisher’s exact test or chi-square test for categorical variables and Mann-Whitney U test for continuous variables. P val","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75099142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信